Back
ARS Pharmaceuticals Vs. IGC Pharma Industry Stock Comparison
Sell
35
SPRY
ARS Pharmaceuticals
Last Price:
14.87
Seasonality Move:
-2.91%
Sell
35
IGC
IGC Pharma
Last Price:
0.34
Seasonality Move:
-3.81%
Sell
35
ARS Pharmaceuticals (SPRY)
is a Sell
Is ARS Pharmaceuticals a Buy, Sell or Hold?
- The current ARS Pharmaceuticals [SPRY] share price is $14.05. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- SPRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.34. The Score for IGC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRY Stock Price Chart
What is ARS Pharmaceuticals's stock price today?
-
The ARS Pharmaceuticals share price today is $14.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing slight buying pressure.
SPRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 63.23 | Buy |
| Chaikin Money Flow: | 629993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.04 - 13.82) | Buy |
| Bollinger Bands (100): | (8.53 - 12.15) | Buy |
IGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 34.53 | Sell |
| Chaikin Money Flow: | 2584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.34 - 0.4) | Sell |
| Bollinger Bands (100): | (0.38 - 0.5) | Sell |
SPRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.65 | Buy |
| 20-day SMA: | 12.71 | Buy |
| 50-day SMA: | 11.83 | Buy |
| 200-day SMA: | 8.83 | Buy |
| 8-day EMA: | 12.95 | Buy |
| 20-day EMA: | 12.6 | Buy |
| 50-day EMA: | 11.79 | Buy |
| 200-day EMA: | 9.39 | Buy |
IGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.36 | Sell |
| 20-day SMA: | 0.36 | Sell |
| 50-day SMA: | 0.4 | Sell |
| 200-day SMA: | 0.4 | Sell |
| 8-day EMA: | 0.35 | Sell |
| 20-day EMA: | 0.37 | Sell |
| 50-day EMA: | 0.39 | Sell |
| 200-day EMA: | 0.4 | Sell |
ARS Pharmaceuticals Earnings Growth & SPRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.26 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
ARS Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IGC Pharma Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||